Table 1 Characteristics of the Patients at Baseline
From: Neo-adjuvant chemotherapy plus immunotherapy in resectable N1/N2 NSCLC
Age | 64 (41–67) |
Sex | |
Male Female | 69 (92%) 6 (8%) |
Smoking history | |
Current/former Never | 67 (89%) 8 (11%) |
Tumour lesion size, mm | |
Median (range) | 39 (15–67) |
Nodal stage | |
N1 N2 | 26 (35%) 49 (65%) |
TNM stage | |
IIb IIIa IIIb | 24 (32%) 41 (55%) 10 (13%) |
Histology | |
Squamous-cell carcinoma Adenocarcinoma | 60 (80%) 15 (20%) |
PD-L1 expression | |
< 1% 1–50% ≥ 50% NA | 21 (28%) 21 (28%) 10 (13%) 23 (31%) |